INNERVATE RADIOPHARMACEUTICALS Trademark
Trademark Overview
On Tuesday, September 30, 2025, a trademark application was filed for INNERVATE RADIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the INNERVATE RADIOPHARMACEUTICALS trademark a serial number of 99420358. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, May 19, 2026. This trademark is owned by INNERVATE RADIOPHARMACEUTICALS LLC. The INNERVATE RADIOPHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:
Anticancer pharmaceutical compounds in the nature of pharmaceutical preparations for the treatment of cancer; therapeutic radiopharmaceutical preparations for the treatment of cancer; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the imaging of cancer, neurological and cardiovascular diseases; radiopharmaceutical diagnostic preparations for medical use; diagnostic biomarker reagents for medical testing; diagnostic preparations and materials in the nature of diagnostic reagents for medical purposes; companion diagnostic agents, diagnostic biomarker reagents, imaging agents for magnetic resonance imaging, positron emission tomography (PET) imaging compounds in the nature of imaging agents, all for medical purposes
General Information
| Serial Number | 99420358 |
| Word Mark | INNERVATE RADIOPHARMACEUTICALS |
| Filing Date | Tuesday, September 30, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Tuesday, May 19, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| NOT AVAILABLE | RADIOPHARMACEUTICALS |
| Goods and Services | Anticancer pharmaceutical compounds in the nature of pharmaceutical preparations for the treatment of cancer; therapeutic radiopharmaceutical preparations for the treatment of cancer; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the imaging of cancer, neurological and cardiovascular diseases; radiopharmaceutical diagnostic preparations for medical use; diagnostic biomarker reagents for medical testing; diagnostic preparations and materials in the nature of diagnostic reagents for medical purposes; companion diagnostic agents, diagnostic biomarker reagents, imaging agents for magnetic resonance imaging, positron emission tomography (PET) imaging compounds in the nature of imaging agents, all for medical purposes |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | INNERVATE RADIOPHARMACEUTICALS LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Englewood, NJ 07631
US |
Trademark Events
| Event Date | Event Description |
| Tuesday, September 30, 2025 | NEW APPLICATION ENTERED |
| Tuesday, September 30, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 30, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, February 4, 2026 | ASSIGNED TO EXAMINER |
| Monday, February 9, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, February 9, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, February 9, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 8, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 8, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 8, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 14, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 14, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 14, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 14, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, May 19, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
